LAST CHANCE TO SAVE! New Trends for Food at PACK EXPO Southeast
Discover all the latest packaging & processing solutions for food products at the all-new PACK EXPO Southeast in Atlanta, GA, March 10-12, 2025
Register ASAP for just $30!

Amgen Employs Cyclic Olefin Polymer for Vials

West’s vial and closure container system help genetically modified herpes simplex virus type 1 therapy withstand cold storage, reduce breakage risks and provide barrier against extractables without compromising seal integrity.

Shown here are West's Daikyo Crystal Zenith® vials.
Shown here are West's Daikyo Crystal Zenith® vials.

Late last year, biotechnology firm Amgen announced that the U.S. FDA approved the Thousand Oaks, CA-based company’s biologics license application for IMLYGIC™ (talimogene laherparepvec), a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous and nodal lesions in patients with melanoma recurrent after initial surgery.